npj Vaccines (Mar 2022)

Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant

  • Kevin K. Ariën,
  • Leo Heyndrickx,
  • Johan Michiels,
  • Katleen Vereecken,
  • Kurt Van Lent,
  • Sandra Coppens,
  • Betty Willems,
  • Pieter Pannus,
  • Geert A. Martens,
  • Marjan Van Esbroeck,
  • Maria E. Goossens,
  • Arnaud Marchant,
  • Koen Bartholomeeusen,
  • Isabelle Desombere

DOI
https://doi.org/10.1038/s41541-022-00459-z
Journal volume & issue
Vol. 7, no. 1
pp. 1 – 3

Abstract

Read online

Abstract We report the levels of neutralising antibodies against Wuhan, Delta and Omicron variants in unimmunized infected (group 1), immunised and boosted (group 2) and infected immunised and boosted (group 3) adult individuals. Our observations support the rapid administration of a booster vaccine dose to prevent infection and disease caused by Omicron.